Skip to main content

4 Result(s)

within Qingjian Wu Remove this filter Rheumatology Remove this filter

and

  1. Article

    Open Access

    Interleukin-4 Modulates Neuroinflammation by Inducing Phenotypic Transformation of Microglia Following Subarachnoid Hemorrhage

    Neuroinflammation, a key pathological feature following subarachnoid hemorrhage (SAH), can be therapeutically targeted by inhibiting microglia M1 polarization and promoting phenotypic transformation to M2 micr...

    **g Wang, Lili Wang, Qingjian Wu, Yichen Cai, Chengfu Cui, Ming Yang… in Inflammation (2024)

    Download PDF (4651 KB) View Article

  2. Article

    Author Correction: Roflumilast Reduces Cerebral Inflammation in a Rat Model of Experimental Subarachnoid Hemorrhage

    Qingjian Wu, Lifeng Qi, Hanxia Li, Leilei Mao, Mingfeng Yang, Rongxia **e… in Inflammation (2023)

    Download PDF (667 KB) View Article

  3. No Access

    Article

    Effectiveness of thalidomide for ankylosing spondylitis: a meta-analysis of randomized controlled trials in China

    Several studies have demonstrated the benefits of thalidomide as a treatment for patients with ankylosing spondylitis (AS); however, published literature reported controversial results. We conducted a meta-ana...

    Dongsen Wang, Xuemei Hu, Xuan Yin, Chunying Cui, Xue Yang… in Clinical Rheumatology (2022)

  4. No Access

    Article

    Roflumilast Reduces Cerebral Inflammation in a Rat Model of Experimental Subarachnoid Hemorrhage

    Roflumilast, a selective inhibitor for PDE4, is approved by FDA as an anti-inflammation drug for treatment of chronic obstructive pulmonary disease (COPD). This study investigates the effects of roflumilast on...

    Qingjian Wu, Lifeng Qi, Hanxia Li, Leilei Mao, Mingfeng Yang, Rongxia **e… in Inflammation (2017)